FNY Investment Advisers’s Amicus Therapeutics FOLD Stock Holding History

FNY Investment Advisers’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-278,670	Closed	-$4.03M	–	922
2026 Q1	$4.03M	Buy	278,670 +242,970	+681%	+$3.48M	1.76%	9
2025 Q4	$508K	Buy	35,700 +30,240	+554%	+$297K	0.14%	142
2025 Q3	$43K	Buy	+5,460	New	+$38.9K	0.01%	532
2018 Q4	–	Sell	-10,000	Closed	-$110K	–	787
2018 Q3	$120K	Buy	10,000 +7,000	+233%	+$97.9K	0.03%	248
2018 Q2	$46K	Buy	+3,000	New	+$45.4K	0.02%	288

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's FOLD Position: Q2 2026 in Review

FNY Investment Advisers sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 278,670 shares — an estimated $4.03M sold.

FNY Investment Advisers first reported a position in FOLD in Q2 2018 and held it in 5 quarters. The position peaked at $4.03M in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

FNY Investment Advisers reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
FNY Investment Advisers sold 278,670 Amicus Therapeutics shares in Q2 2026, an estimated $4.03M.
FNY Investment Advisers first reported a position in Amicus Therapeutics in Q2 2018 and held it in 5 quarters.
FNY Investment Advisers's Amicus Therapeutics position peaked at $4.03M in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.